The Hawaii State Department of Health today approved a petition to add Amyotrophic Lateral Sclerosis (ALS) as a qualifying condition for the medical use of cannabis in the State of Hawaii. In addition to the petition, DOH considered public testimony, laws and policies of medical cannabis programs in other states, and published scientific literature.
A portion of the response reads, “Despite the limited medical evidence available, give the severity, progressive degeneration, limited treatment options, and generally poor prognosis of ALS, and in the context of Hawaii’s laws and policies, DOH finds that it is reasonable that the appropriateness of medical cannabis for ALS patients should be determined through a comprehensive assessment by the patients’ physician or APRN and a risk-benefit discussion.”
Under the DOH medical cannabis registry program, individuals with ALS can be considered for registry as medical cannabis patients.
It is the Alliance’s mission to provide up-to-date and relevant industry information to the patients, current and future dispensaries, and related businesses of Hawai‘i’s growing medicinal cannabis industry. If you are not yet a member of the Hawai‘i Dispensary Alliance, join today to receive Cannabis Insider bi-monthly, and take an active role in the future of Hawai‘i’s medical marijuana industry. Contact us today and we will send you the Cannabis Insider November/December 2017 edition absolutely free. You can also find us on Facebook or Twitter. Raise your voice, take action, and join the Hawai‘i Dispensary Alliance today.